Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.   

Innovation: Key to Success in the Pharmaceutical Industry

The Industry Challenge: Do You Really Want to Be in This Business?
The Science and Technology Challenge: How to Find New Drugs
The Pipeline Management Challenge: How to Organize Innovation
The Internationalization Challenge: Where to Get Access to Innovation
Management Answers to Pharmaceutical R&D Challenges
Future Directions and Trends.